571 related articles for article (PubMed ID: 19617412)
1. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
3. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase.
Moriguchi A; Otani H; Yoshioka K; Shimazu T; Fujita M; Okazaki T; Sato D; Kyoi S; Iwasaka T
Circ J; 2010 Nov; 74(11):2393-402. PubMed ID: 20877127
[TBL] [Abstract][Full Text] [Related]
5. Insulin and GSK3β-inhibition abrogates the infarct sparing-effect of ischemic postconditioning in ex vivo rat hearts.
Helgeland E; Wergeland A; Sandøy RM; Askeland M; Aspevik A; Breivik L; Jonassen AK
Scand Cardiovasc J; 2017 Jun; 51(3):159-166. PubMed ID: 28276718
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
8. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
9. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
Xie H; Zhang J; Zhu J; Liu LX; Rebecchi M; Hu SM; Wang C
Acta Pharmacol Sin; 2014 Dec; 35(12):1504-13. PubMed ID: 25345742
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
[TBL] [Abstract][Full Text] [Related]
12. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
[TBL] [Abstract][Full Text] [Related]
15. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
16. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.
Deschamps AM; Murphy E
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1806-13. PubMed ID: 19717735
[TBL] [Abstract][Full Text] [Related]
17. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
Morrison A; Yan X; Tong C; Li J
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
[TBL] [Abstract][Full Text] [Related]
18. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.
Xu Y; Ma LL; Zhou C; Zhang FJ; Kong FJ; Wang WN; Qian LB; Wang CC; Liu XB; Yan M; Wang JA
PLoS One; 2013; 8(10):e76652. PubMed ID: 24124583
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
